表紙
市場調査レポート

小線源治療装置の世界市場:2015-2019年

Global Brachytherapy Devices Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 260031
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
小線源治療装置の世界市場:2015-2019年 Global Brachytherapy Devices Market 2015-2019
出版日: 2015年07月29日 ページ情報: 英文 82 Pages
概要

世界の小線源治療装置の市場は、2015年から2019年にかけて2.88%のCAGRで拡大する見込みです。

当レポートでは、世界の小線源治療装置の市場を調査し、放射線治療の概要、癌の罹患率と発症率、小線源治療の種類と概要、小線源治療装置の地域別の市場規模の推移と予測、市場への各種影響因子の分析、競合環境、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 調査手法

第5章 イントロダクション

第6章 放射線治療:概要

  • 体外ビーム照射療法
  • 内部放射線治療
  • 体外ビーム照射療法と内部放射線治療の違い

第7章 市場環境

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第8章 癌:罹患率・発症率

第9章 癌の種類別市場

  • 世界の小線源治療装置市場:癌の種類別
  • 前立腺癌
  • 乳癌
  • 子宮頸癌
  • 皮膚癌

第10章 手法別市場

  • HDR (高線量率) 小線源療法
  • LDR (低線量率) 小線源療法
  • MDR
  • PDR

第11章 地域分析

  • 南北アメリカ
    • 市場規模・予測
  • 欧州・中東・アフリカ
    • 市場規模・予測
  • アジア太平洋
    • 市場規模・予測

第12章 購入基準

第13章 市場成長因子

第14章 成長因子とその影響

第15章 市場の課題

第16章 成長因子と課題の影響

第17章 市場動向

第18章 市場動向とその影響

第19章 ベンダー環境

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 主要ベンダーの分析
    • C.R. Bard
    • Eckert & Ziegler
    • Elekta
    • Theragenics
    • Varian Medical Systems
  • 他の有力ベンダー

第20章 主要ベンダーの分析

  • C.R. Bard
  • Eckert & Ziegler
  • Elekta
  • Theragenics
  • Varian Medical Systems
    • 主要データ
    • 事業概要
    • 事業区分
    • 事業別収益
    • 地域別収益
    • 事業戦略
    • 発展動向
    • SWOT分析、など

第21章 関連レポート

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6738

About Brachytherapy Devices

Radiation therapy uses ionizing radiation to treat cancer. It comprises internal radiation therapy (brachytherapy) and external radiation therapy. In brachytherapy, radioactive material is placed near or next to the tumor. It uses higher doses of radiation to treat a small area. It is suitable for smaller and early-stage tumours, and is used in the treatment of various cancers, including gynaecological and prostate cancer. Brachytherapy can also be combined with other radiation therapies to treat cancer. The radioactive materials used for brachytherapy include: cesium, gold, iodine, iridium, and palladium.

Technavio's analysts forecast the global brachytherapy devices market to grow at a CAGR of 2.88% during the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global brachytherapy devices market for the period 2015-2019.

Technavio's report, Global Brachytherapy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the global brachytherapy devices market landscape and its growth prospects over the coming years. The report also includes a discussion on the key vendors operating in this market.

Key Geographies

  • Americas
  • APAC
  • EMEA

Key Vendors

  • CR Bard
  • Eckert and Zieglar BEBIG
  • Elekta
  • Theragenics
  • Varian Medical Systems

Other Prominent Vendors

  • Boston Scientific
  • CIVCO Medical Instruments
  • CONMED
  • Cook Medical
  • Gammex
  • GE Healthcare
  • Huiheng Medical
  • IsoRay Medical
  • Olympus

Market Driver

  • Increasing Incidence of Cancer
  • For a full, detailed list, view our report

Market Challenge

  • Technical Advancements in EBRT
  • For a full, detailed list, view our report

Market Trend

  • Epimacular Brachytherapy
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Radiation Therapy: An Overview

  • 06.1. External Beam Radiation Therapy
  • 06.2. Internal Radiation Therapy
  • 06.3. Differences Between External Beam Radiation Therapy and Internal Radiation Therapy

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Cancer: Rate of Incidence and Prevalence

09. Market Segmentation by Type of Cancer

  • 09.1. Global Brachytherapy Devices Market by Type of Cancer
  • 09.2. Prostate Cancer
  • 09.3. Breast Cancer
  • 09.4. Cervical Cancer
  • 09.5. Skin Cancer

10. Market Segmentation by Method

  • 10.1. HDR Brachytherapy
  • 10.2. LDR Brachytherapy
  • 10.3. MDR
  • 10.4. PDR

11. Geographical Segmentation

  • 11.1. Brachytherapy Devices Market in Americas
    • 11.1.1. Market Size and Forecast
  • 11.2. Brachytherapy Devices Market in EMEA
    • 11.2.1. Market Size and Forecast
  • 11.3. Brachytherapy Devices Market in APAC
    • 11.3.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Major Vendor Analysis 2014
    • 19.2.1. C.R. Bard
    • 19.2.2. Eckert & Ziegler
    • 19.2.3. Elekta
    • 19.2.4. Theragenics
    • 19.2.5. Varian Medical Systems
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. C.R. Bard
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Product Segmentation by Revenue 2013
    • 20.1.4. Product Segmentation by Revenue 2012 and 2013
    • 20.1.5. Sales by Geography
    • 20.1.6. Business Strategy
    • 20.1.7. Key Developments
    • 20.1.8. SWOT Analysis
    • 20.1.9. Strengths
    • 20.1.10. Weakness
    • 20.1.11. Opportunities
    • 20.1.12. Threats
  • 20.2. Eckert & Ziegler
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Revenue Segmentation 2013 and 2014
    • 20.2.4. Geographical Segmentation by Revenue 2014
    • 20.2.5. Recent Developments
    • 20.2.6. SWOT Analysis
  • 20.3. Elekta
    • 20.3.1. Key Facts
    • 20.3.2. Business Description
    • 20.3.3. Product Categorization
    • 20.3.4. Revenue Segmentation by Product Offerings
    • 20.3.5. Revenue Comparison across Geographies
    • 20.3.6. Sales by Geographical Segmentation
    • 20.3.7. Business Strategy
    • 20.3.8. Key Developments
    • 20.3.9. SWOT Analysis
  • 20.4. Theragenics
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation
    • 20.4.4. End-markets
    • 20.4.5. Recent Developments
    • 20.4.6. SWOT Analysis
  • 20.5. Varian Medical Systems
    • 20.5.1. Key Facts
    • 20.5.2. Business Description
    • 20.5.3. Business Segmentation
    • 20.5.4. Revenue Segmentation by Business
    • 20.5.5. Segmental Revenue Comparison 2013 and 2012
    • 20.5.6. Sales by Geographical Segmentation
    • 20.5.7. Business Strategy
    • 20.5.8. Key Developments
    • 20.5.9. SWOT Analysis

21. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Types of Radiation Therapy
  • Exhibit 3: Factors Affecting Outcome of Radiation Therapy
  • Exhibit 4: Global Brachytherapy Devices Market 2014-2019 ($ millions)
  • Exhibit 5: Percentage of Cancer Cases
  • Exhibit 6: Global Brachytherapy Devices Market by Type of Cancer
  • Exhibit 7: Global Brachytherapy Devices Market by Method
  • Exhibit 8: Global Brachytherapy Devices Market by Geography 2014
  • Exhibit 9: Global Brachytherapy Devices Market by Geography 2014-2019
  • Exhibit 10: Brachytherapy Devices Market in Americas 2014-2019 ($ millions)
  • Exhibit 11: Brachytherapy Devices Market in EMEA 2014-2019 ($ millions)
  • Exhibit 12: Brachytherapy Devices Market in APAC 2014-2019 ($ millions)
  • Exhibit 13: Key Takeaways: C.R. Bard
  • Exhibit 14: Key Takeaways: Eckert & Ziegler
  • Exhibit 15: Key Takeaways: Elekta
  • Exhibit 16: Key Takeaways: Theragenics
  • Exhibit 17: Key Takeaways: Varian Medical Systems
  • Exhibit 18: C.R. Bard: Product Segmentation by Revenue 2013
  • Exhibit 19: C.R. Bard: Product Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 20: C.R. Bard: Sales by Geography (2013)
  • Exhibit 21: Eckert & Ziegler: Revenue Segmentation 2013 and 2014 ($ millions)
  • Exhibit 22: Eckert & Ziegler: Geographical Segmentation by Revenue 2014
  • Exhibit 23: Product Categorization of Elekta
  • Exhibit 24: Revenue Segmentation of Elekta 2013
  • Exhibit 25: Revenue Comparison ($ millions)
  • Exhibit 26: Revenue Segmentation of Elekta by Geography 2013
  • Exhibit 27: Theragenics: Business Segmentation
  • Exhibit 28: Theragenics: End-markets
  • Exhibit 29: Business Segmentation of Varian Medical Systems
  • Exhibit 30: Revenue Segmentation of Varian Medical Systems 2013
  • Exhibit 31: Revenue Comparison ($ millions)
  • Exhibit 32: Revenue Segmentation of Varian Medical Systems by Geography 2013
Back to Top